These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 11329777)
41. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053 [TBL] [Abstract][Full Text] [Related]
42. Chemotherapy for head and neck cancer. Tannock IF J Otolaryngol; 1984 Apr; 13(2):99-104. PubMed ID: 6202878 [TBL] [Abstract][Full Text] [Related]
43. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901 [TBL] [Abstract][Full Text] [Related]
44. [The present situation of neoadjuvant therapy for head and neck carcinoma]. Rikimaru F; Tomita K Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367 [TBL] [Abstract][Full Text] [Related]
45. Induction chemotherapy for head and neck cancer: recent data. Vokes EE Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882 [TBL] [Abstract][Full Text] [Related]
46. [Development of treatments for head and neck squamous cell carcinomas]. Tsukuda M Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():85-96. PubMed ID: 10410663 [TBL] [Abstract][Full Text] [Related]
47. [Advances in the treatment of head and neck tumors. I. Chemotherapy]. Stupp R; Vokes EE Strahlenther Onkol; 1995 Jan; 171(1):12-7. PubMed ID: 7839300 [TBL] [Abstract][Full Text] [Related]
48. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. Argiris A; Li Y; Murphy BA; Langer CJ; Forastiere AA J Clin Oncol; 2004 Jan; 22(2):262-8. PubMed ID: 14722034 [TBL] [Abstract][Full Text] [Related]
49. Emerging drugs for head and neck cancer. Rhee JC; Khuri FR; Shin DM Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138 [TBL] [Abstract][Full Text] [Related]
50. RADPLAT: an alternative to surgery? Alkureishi LW; de Bree R; Ross GL Oncologist; 2006 May; 11(5):469-80. PubMed ID: 16720847 [TBL] [Abstract][Full Text] [Related]
51. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. Zorat PL; Paccagnella A; Cavaniglia G; Loreggian L; Gava A; Mione CA; Boldrin F; Marchiori C; Lunghi F; Fede A; Bordin A; Da Mosto MC; Sileni VC; Orlando A; Jirillo A; Tomio L; Pappagallo GL; Ghi MG J Natl Cancer Inst; 2004 Nov; 96(22):1714-7. PubMed ID: 15547184 [TBL] [Abstract][Full Text] [Related]
52. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118 [TBL] [Abstract][Full Text] [Related]
53. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study. Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494 [TBL] [Abstract][Full Text] [Related]
54. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Wang HM; Wang CS; Chen JS; Chen IH; Liao CT; Chang TC Cancer; 2002 Jun; 94(11):2989-95. PubMed ID: 12115388 [TBL] [Abstract][Full Text] [Related]
55. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833 [TBL] [Abstract][Full Text] [Related]
56. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Stolwijk C; Wagener DJ; Van den Broek P; Levendag PC; Kazem I; Bruaset I; De Mulder PH Neth J Med; 1985; 28(9):347-51. PubMed ID: 2413379 [No Abstract] [Full Text] [Related]
57. [Multidisciplinary treatment for organ/function preservation in head and neck cancer]. Inuyama Y Hokkaido Igaku Zasshi; 1994 May; 69(3):396-402. PubMed ID: 7927168 [TBL] [Abstract][Full Text] [Related]
58. [Critical remarks on chemotherapy of malignant tumors of the head and neck]. Ganzer U; Bier H; Bachert C Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):200-4. PubMed ID: 2439860 [TBL] [Abstract][Full Text] [Related]
59. [Induction chemotherapy in patients with head and neck cancer]. Chaigneau L; Guardiola E; N'Guyen T; Dufresne A; Stein U; Villanueva C; Thiery-Vuillemin A; Lorchel F; Pivot X Bull Cancer; 2006 Jul; 93(7):677-82. PubMed ID: 16873076 [TBL] [Abstract][Full Text] [Related]
60. Chemotherapy for head and neck cancer: progress and controversy in the management of patients with M0 disease. Clark JR; Frei E Semin Oncol; 1989 Aug; 16(4 Suppl 6):44-57. PubMed ID: 2669137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]